Opportunity Information: Apply for RFA CK 11 007

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza like Illness (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
  • This funding opportunity was created on Feb 14, 2011 and posted on Feb 14, 2011.
  • Applicants must submit their applications by Mar 29, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for RFA CK 11 007

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Centers for Disease Control and Prevention (CDC) released a discretionary funding opportunity, RFA-CK-11-007, titled "Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-like Illness (U01)." The grant is structured as a cooperative agreement, meaning CDC would be actively involved with awardees during the project rather than simply providing funds with minimal federal engagement. The overall intent is to support applied research that tests how well different "stay home" or exclusion rules work in real-world settings to reduce the spread of influenza-like illness (ILI) and laboratory-confirmed influenza. The focus is practical: when people develop symptoms, which exclusion criteria meaning how soon they should leave, how long they should remain out, and what conditions should be met before returning actually leads to fewer infections among coworkers, patients, students, or classmates.

The core research goal is to determine the effectiveness of alternative illness exclusion criteria across multiple environments. CDC is specifically interested in evidence from healthcare workplaces, non-healthcare workplaces, and school settings. These contexts matter because transmission dynamics, exposure intensity, contact patterns, and consequences of illness differ substantially between, for example, a hospital unit, an office environment, and a classroom. The studies supported under this announcement are expected to directly assess whether particular exclusion policies prevent additional cases of ILI and confirmed influenza, rather than relying only on theory or modeling. In other words, the opportunity aims to generate decision-ready evidence that can inform public health guidance and employer or school policies during seasonal influenza periods and potentially during more severe outbreaks.

Funding details indicate CDC anticipated making two awards under this announcement, with an award ceiling of $1,000,000 and no stated minimum award amount (award floor of $0). The CFDA listing is 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance). There is no cost-sharing or matching requirement, which generally lowers the barrier for applicants because they are not required to contribute non-federal funds to the project budget. Eligibility is listed as unrestricted, meaning the competition was open to any entity type, subject to any additional clarifications that may have been included in the full announcement. The opportunity was posted and created on February 14, 2011, with an original and current closing date of March 29, 2011, and an archive date of April 28, 2011, indicating it is a past (archived) funding announcement rather than an active competition.

In practical terms, an applicant responding to this opportunity would be proposing a study design capable of comparing exclusion criteria in a way that yields credible conclusions. That could involve comparing shorter versus longer exclusion periods, symptom-based versus fever-based rules, return-to-work or return-to-school requirements, or different screening and notification approaches tied to exclusion decisions. Because CDC emphasized both ILI outcomes and laboratory-confirmed influenza outcomes, a strong project concept would typically incorporate methods to capture syndromic illness data while also collecting specimens or otherwise confirming influenza infections through lab testing, enabling the study to distinguish influenza from other respiratory viruses that can look similar clinically.

Administrative details in the synopsis note that the full announcement link was not active in the summary view and that applicants needing help accessing the complete materials were directed to contact CDCs Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), by phone at 770-488-2700. This contact point would have supported prospective applicants with technical access issues or questions about the application package and requirements contained in the full announcement.

Frequently Asked Questions (FAQs)

What is the name and number of this CDC funding opportunity?

The opportunity is titled "Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-like Illness (U01)" and is identified as RFA-CK-11-007.

Which federal agency is offering this grant?

The funding opportunity was released by the Centers for Disease Control and Prevention (CDC).

What type of funding mechanism is used?

This opportunity is structured as a cooperative agreement (U01). That means CDC would be actively involved with awardees during the project, rather than only providing funding with minimal federal engagement.

What is the main purpose of the funded research?

The intent is to support applied research that evaluates how well different "stay home" or illness exclusion rules work in real-world settings to reduce the spread of influenza-like illness (ILI) and laboratory-confirmed influenza.

What are "exclusion criteria" in the context of this opportunity?

What outcomes is CDC looking for projects to measure?

Projects are expected to directly assess whether specific exclusion policies prevent additional cases of influenza-like illness (ILI) and laboratory-confirmed influenza.

Does CDC want theoretical or modeling-only studies?

The emphasis is on real-world, applied evidence that directly assesses whether particular exclusion policies reduce illness spread, rather than relying only on theory or modeling.

Which settings are of particular interest?

CDC is specifically interested in evidence from multiple environments, including healthcare workplaces, non-healthcare workplaces, and school settings.

Why does the setting (healthcare workplace vs. office vs. school) matter for this research?

The synopsis notes that transmission dynamics and related factors can differ substantially by setting, including exposure intensity, contact patterns, and the consequences of illness.

What kinds of exclusion policies might a study compare under this announcement?

The synopsis suggests studies could compare alternatives such as shorter versus longer exclusion periods, symptom-based versus fever-based rules, return-to-work or return-to-school requirements, or different screening and notification approaches tied to exclusion decisions.

Is laboratory testing expected, or is symptom tracking enough?

CDC emphasized both ILI outcomes and laboratory-confirmed influenza outcomes. A strong project concept would typically include ways to capture syndromic (ILI) data and also collect specimens or otherwise confirm influenza through lab testing to distinguish influenza from other respiratory viruses that look similar.

How many awards did CDC anticipate making?

CDC anticipated making two awards under this announcement.

What is the maximum funding amount?

The award ceiling listed in the synopsis is $1,000,000.

Is there a minimum award amount?

No minimum award amount is stated in the synopsis (an award floor of $0 is listed).

Is cost sharing or matching required?

No. The synopsis states there is no cost-sharing or matching requirement.

Who was eligible to apply?

Eligibility is listed as unrestricted, meaning the competition was open to any entity type, subject to any additional clarifications that may have been included in the full announcement.

What is the CFDA number associated with this opportunity?

The CFDA listing provided is 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance).

When was the opportunity posted and when did it close?

The synopsis states it was posted/created on February 14, 2011. The original and current closing date is March 29, 2011.

Is this opportunity still open?

No. The synopsis indicates an archive date of April 28, 2011, which means it is a past (archived) funding announcement rather than an active competition.

Where could applicants get help if the full announcement link was not accessible?

The synopsis notes that the full announcement link was not active in the summary view. Applicants needing help accessing complete materials were directed to contact CDC's Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), at 770-488-2700.

What is the practical end use of the research results?

The opportunity aims to generate decision-ready evidence that can inform public health guidance and employer or school policies during seasonal influenza periods and potentially during more severe outbreaks.

Browse more: School Grants

Browse more business programs for Influenza Research

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Limited Competition Specific pathogen free macaque colonies (U42)

Previous opportunity: Provision of HIV/AIDS Treatment Services by Local Indigenous Entities in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CK 11 007

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CK 11 007) also looked into and applied for these:

Funding Opportunity
Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01) Apply for PA 11 121

Funding Number: PA 11 121
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strengthening the Capacity of Institutions of Uniformed Services in the Federal Democratic Republic of Ethiopia to Deliver Comprehensive HIV/AIDS Prevention, Care, Treatment, and Support Services under the President s Emergency Plan for AIDS Relief Apply for CDC RFA GH11 1166

Funding Number: CDC RFA GH11 1166
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $6,101,253
Supporting the Rwandan Ministry of Health with Transition to Achieve Sustainable Public Health Program Implementation under the President s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Initiative Apply for CDC RFA GH11 1187

Funding Number: CDC RFA GH11 1187
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Institutional Strengthening to Improve Quality of Health Care Services in Haiti Through Well Trained Health Care Professional under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11100

Funding Number: CDC RFA GH11 11100
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS11 1115

Funding Number: CDC RFA PS11 1115
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $125,000
Addressing TB Control and Lung Health Activities through the Vietnam National Lung Hospital/National TB Program (NLH/NTP) Apply for CDC RFA PS11 1110

Funding Number: CDC RFA PS11 1110
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Strengthening Human Resources for Health through Continuing Education of Health Workers in the Federal Democratic Republic of Ethiopia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1167

Funding Number: CDC RFA GH11 1167
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $500,000
Supporting The Implementation And Evaluation Of HIV/AIDS And Other Infectious And Non Infectious Diseases, Emerging Infections And Neglected Tropical Diseases In The Republic Of Nigeria Under PEPFAR Apply for CDC RFA PS09 9610301SUPP11

Funding Number: CDC RFA PS09 9610301SUPP11
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Providing Technical Assistance for the Development and Implementation of Government of Botswana Driven Multi Component National HIV Prevention Campaigns under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1141

Funding Number: CDC RFA GH11 1141
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Technical Assistance to Strengthen and Ensure the Sustainability of the United Republic of Tanzania s Field Laboratory Epidemiology Training Program (FELTP) under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1143

Funding Number: CDC RFA GH11 1143
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $4,000,000
Strengthening Infection Control and Prevention in Health Care Facilities in Zimbabwe under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1144

Funding Number: CDC RFA GH11 1144
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
NHLBI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30) Apply for PA 11 125

Funding Number: PA 11 125
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21) Apply for PA 11 124

Funding Number: PA 11 124
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01) Apply for PA 11 123

Funding Number: PA 11 123
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Silvio O. Conte Centers for Basic and Translational Mental Health Research (P50) Apply for PAR 11 126

Funding Number: PAR 11 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Virologic Evaluation of the Modes of Influenza Virus Transmission among Humans (U01) Apply for RFA IP 11 001

Funding Number: RFA IP 11 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
NIH HMO Collaboratory Coordinating Center Limited Competition (U54) Apply for RFA RM 11 003

Funding Number: RFA RM 11 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chemical Approaches to Target Validation for Drug Resistant Pathogens (R01) Apply for RFA AI 11 004

Funding Number: RFA AI 11 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
APHL CDC PARTNERSHIP FOR QUALITY LABORATORY MEDICINE Apply for CDC RFA HM10 100102CONT11

Funding Number: CDC RFA HM10 100102CONT11
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Combined Multipurpose Strategies for Sexual and Reproductive Health (R21/33) Apply for RFA AI 11 016

Funding Number: RFA AI 11 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 11 007", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.